253 related articles for article (PubMed ID: 37094727)
1. GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit.
Umbarkar P; Ruiz Ramirez SY; Toro Cora A; Tousif S; Lal H
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166724. PubMed ID: 37094727
[TBL] [Abstract][Full Text] [Related]
2. Cardiac fibroblast GSK-3α aggravates ischemic cardiac injury by promoting fibrosis, inflammation, and impairing angiogenesis.
Umbarkar P; Ejantkar S; Ruiz Ramirez SY; Toro Cora A; Zhang Q; Tousif S; Lal H
Basic Res Cardiol; 2023 Sep; 118(1):35. PubMed ID: 37656238
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.
Umbarkar P; Tousif S; Singh AP; Anderson JC; Zhang Q; Tallquist MD; Woodgett J; Lal H
Circ Res; 2022 Sep; 131(7):620-636. PubMed ID: 36052698
[TBL] [Abstract][Full Text] [Related]
4. The GSK-3 family as therapeutic target for myocardial diseases.
Lal H; Ahmad F; Woodgett J; Force T
Circ Res; 2015 Jan; 116(1):138-49. PubMed ID: 25552693
[TBL] [Abstract][Full Text] [Related]
5. Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure.
Tariq U; Uppulapu SK; Banerjee SK
Curr Drug Targets; 2021; 22(13):1568-1576. PubMed ID: 33655828
[TBL] [Abstract][Full Text] [Related]
6. Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.
Lal H; Ahmad F; Zhou J; Yu JE; Vagnozzi RJ; Guo Y; Yu D; Tsai EJ; Woodgett J; Gao E; Force T
Circulation; 2014 Jul; 130(5):419-30. PubMed ID: 24899689
[TBL] [Abstract][Full Text] [Related]
7. GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice.
Zhou J; Lal H; Chen X; Shang X; Song J; Li Y; Kerkela R; Doble BW; MacAulay K; DeCaul M; Koch WJ; Farber J; Woodgett J; Gao E; Force T
J Clin Invest; 2010 Jul; 120(7):2280-91. PubMed ID: 20516643
[TBL] [Abstract][Full Text] [Related]
8. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
9. A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase.
Sale EM; Hodgkinson CP; Jones NP; Sale GJ
Biochemistry; 2006 Jan; 45(1):213-23. PubMed ID: 16388597
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between GSK-3β-actuated molecular cascades and myocardial physiology.
Sharma AK; Bhatia S; Al-Harrasi A; Nandave M; Hagar H
Heart Fail Rev; 2021 Nov; 26(6):1495-1504. PubMed ID: 32314086
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload.
Matsuda T; Zhai P; Maejima Y; Hong C; Gao S; Tian B; Goto K; Takagi H; Tamamori-Adachi M; Kitajima S; Sadoshima J
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20900-5. PubMed ID: 19106302
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells.
Cho J; Rameshwar P; Sadoshima J
J Biol Chem; 2009 Dec; 284(52):36647-36658. PubMed ID: 19858210
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of GSK-3α in pathophysiology: Emphasis on cardio-metabolic disorders.
Ahmad F; Woodgett JR
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118616. PubMed ID: 31785335
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.
Gupte M; Tumuluru S; Sui JY; Singh AP; Umbarkar P; Parikh SS; Ahmad F; Zhang Q; Force T; Lal H
Int J Cardiol; 2018 May; 259():145-152. PubMed ID: 29398139
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.
Ahmad F; Singh AP; Tomar D; Rahmani M; Zhang Q; Woodgett JR; Tilley DG; Lal H; Force T
J Mol Cell Cardiol; 2019 May; 130():65-75. PubMed ID: 30928428
[TBL] [Abstract][Full Text] [Related]
17. Interactomes of Glycogen Synthase Kinase-3 Isoforms.
Cormier KW; Larsen B; Gingras AC; Woodgett JR
J Proteome Res; 2023 Mar; 22(3):977-989. PubMed ID: 36779422
[TBL] [Abstract][Full Text] [Related]
18. Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival.
Liang MH; Chuang DM
J Biol Chem; 2007 Feb; 282(6):3904-17. PubMed ID: 17148450
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity.
Gupte M; Umbarkar P; Singh AP; Zhang Q; Tousif S; Lal H
Cells; 2020 Apr; 9(5):. PubMed ID: 32365965
[TBL] [Abstract][Full Text] [Related]
20. Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy.
Zhou J; Ahmad F; Parikh S; Hoffman NE; Rajan S; Verma VK; Song J; Yuan A; Shanmughapriya S; Guo Y; Gao E; Koch W; Woodgett JR; Madesh M; Kishore R; Lal H; Force T
Circ Res; 2016 Apr; 118(8):1208-22. PubMed ID: 26976650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
